What You Should Know:
– Phenomix Sciences, a leader in precision medicine for obesity, launches a new MyPhenome test that identifies all three key obesity phenotypes in a single test.
– The new test identifies all three of the company’s signature obesity phenotypes in a single assessment, empowering patients and providers with deeper insights for personalized treatment plans.
Understanding Obesity Phenotypes
Obesity phenotypes, a groundbreaking discovery by Phenomix co-founders Drs. Andres Acosta and Michael Camilleri, represent the unique combination of genes and biometrics that contribute to an individual’s weight struggles. A 2024 study revealed that patients with multiple phenotypes tend to have a higher body mass index.
The Three Obesity Phenotypes
The three phenotypes identified by the MyPhenome test are:
- Emotional Hunger: Individuals who eat in response to emotions like stress, anxiety, or depression. Treatment may involve cognitive therapy and medications to manage cravings and increase self-awareness.
- Hungry Gut: Patients with abnormally rapid gastric emptying, leading to frequent hunger pangs. Treatment options include a specialized diet, medications that slow digestion, and potentially certain devices or bariatric surgery.
- Hungry Brain: Individuals with a higher satiety threshold, require more calories to feel full. Treatment may involve a specific diet, medications to regulate appetite, and potentially certain devices or bariatric surgery.
MyPhenome Benefits & Support
The new MyPhenome test offers several advantages:
- Comprehensive Analysis: Identifies all three phenotypes, providing a more complete picture.
- Personalized Insights: Generates a detailed report outlining the patient’s specific phenotype(s) and the underlying cause of their obesity.
- Actionable Guidance: Offers personalized resources, including meal plans and recipes tailored to the patient’s phenotype.
The MyPhenome portal provides additional support:
- Educational Resources: Patients can access information specific to their phenotype.
- Treatment Guidance: The portal helps healthcare providers develop targeted treatment plans, including lifestyle changes, dietary interventions, medications, and potential surgical procedures.
Availability
The new MyPhenome test is now available to healthcare providers across the US.
“The release of our newest test is a testament of our commitment to further understand the complexity of obesity and find ways to solve it,” said Mark Bagnall, CEO of Phenomix Sciences. “This test goes beyond simply providing a yes or no answer; it offers a deeper understanding of the degree to which these phenotypes affect each patient and provides actionable ways to address it. Backed by powerful machine learning and groundbreaking research, this is just the beginning of unlocking the potential of obesity precision medicine.”
